Article Details

Goldman Sachs Remains a Sell on Medtronic (MDT) - The Globe and Mail

Retrieved on: 2025-08-20 16:16:02

Tags for this article:

Click the tags to see associated articles and topics

Goldman Sachs Remains a Sell on Medtronic (MDT) - The Globe and Mail. View article details on hiswai:

Excerpt

In a report released today, David Roman from Goldman Sachs reiterated a Sell rating on Medtronic, with a price target of $78.00.

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo